Spero Therapeutics, Inc.

SPRO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K May 11, 2023 8-K
10-Q May 11, 2023 10-Q
S-8 Mar 30, 2023 S-8
8-K Mar 30, 2023 8-K
10-K Mar 30, 2023 10-K
SC 13G/A Feb 14, 2023 AMENDMENT NO. 5 TO THE SCHEDULE 13G
SC 13G/A Feb 14, 2023
4 Feb 6, 2023 FORM 4 SUBMISSION
4 Feb 3, 2023 FORM 4 SUBMISSION
4 Feb 3, 2023 FORM 4 SUBMISSION
4 Feb 3, 2023 FORM 4 SUBMISSION
4 Feb 3, 2023 FORM 4 SUBMISSION
4 Feb 3, 2023 FORM 4 SUBMISSION
8-K Feb 1, 2023 8-K
SC 13D/A Jan 20, 2023 SCHEDULE 13D/A
CT ORDER Jan 19, 2023
8-K Jan 9, 2023 8-K
4 Jan 5, 2023 FORM 4 SUBMISSION
4 Jan 5, 2023 FORM 4 SUBMISSION
D Nov 15, 2022
3 Nov 14, 2022
SC 13D/A Nov 14, 2022 SCHEDULE 13D/A
S-8 Nov 14, 2022 S-8
8-K Nov 14, 2022 8-K
10-Q Nov 14, 2022 10-Q
← Newer Page 7 of 21 · 513 filings Older →